Hormonal therapy: historical perspective to future directions

This publication has 30 references indexed in Scilit:

• DIETHYLSTILBESTEROL REVISITED: ANDROGEN DEPRIVATION, OSTEOPOROSIS AND PROSTATE CANCER
  Journal of Urology, 2002
• PROSPECTIVE EVALUATION OF HOT FLASHES DURING TREATMENT WITH PARENTERAL ESTROGEN OR COMPLETE ANDROGEN ABLATION FOR METASTATIC CARCINOMA OF THE PROSTATE
  Journal of Urology, 2001
• LHRH analogues as anticancer agents: pituitary and extrapituitary sites of action
  Expert Opinion on Investigational Drugs, 2001
• Cancer Statistics, 2001
  CA: A Cancer Journal for Clinicians, 2001
• Racial Variation in Prostate Cancer Incidence and in Hormonal System Markers Among Male Health Professionals
  JNCI Journal of the National Cancer Institute, 2000
• Parenteral estrogen versus total androgen ablation in the treatment of advanced prostate carcinoma: effects on overall survival and cardiovascular mortality
  Urology, 2000
• Single-agent therapy with bicalutamide: A comparison with medical or surgical castration in the treatment of advanced prostate carcinoma
  Urology, 1995
• Combination Therapy with Flutamide and the LHRH Agonist [D‐Trp⁶, des‐Gly‐NH₂¹⁰]LHRH Ethylamide in Stage C Prostatic Carcinoma
  Published by Wiley ,1993
• Prevention of the Transient Adverse Effects of a Gonadotropin-Releasing Hormone Analogue (Buserelin) in Metastatic Prostatic Carcinoma by Administration of an Antiandrogen (Nilutamide)
  New England Journal of Medicine, 1989
• Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists.
  Proceedings of the National Academy of Sciences, 1982